Skip to main content

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

    • A Comprehensive Guide for Novice Researcher in Clinical Trials

      • 1st Edition
      • May 1, 2026
      • Miltiadis Lytras + 2 more
      • English
      A Comprehensive Guide for Novice Researcher in Clinical Trials is a must-have resource for individuals embarking on the journey of clinical research. This book is tailored for beginners, offering a clear and structured introduction to the vital principles, methodologies, and skills required to design and conduct robust clinical trials. Spanning 13 chapters, it meticulously covers the entire clinical trial process, emphasizing Good Clinical Practice (GCP) standards. From foundational research concepts to advanced trial strategies, the guide empowers readers to confidently navigate the complexities of clinical trials and contribute meaningfully to the field of healthcare.In addition to its foundational content, the book addresses a variety of important topics, such as ethical considerations, regulatory compliance, and the development of trial protocols. It explores different trial designs, types of bias, and the historical evolution of clinical research. Practical sections on data management, monitoring, statistical analysis, and project management offer readers hands-on guidance for real-world application. Notably, the book includes a dedicated focus on regulatory affairs in Saudi Arabia, making it particularly valuable for health professionals in that region.
    • Emerging Trends in Cancer Pharmacology

      • 1st Edition
      • March 1, 2026
      • Tapan Behl + 4 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 1 5 9 2 3
      • eBook
        9 7 8 0 4 4 3 3 1 5 9 3 0
      Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine provides an essential, current overview of progress in cancer pharmacology. The book explores the latest advancements in understanding cancer's molecular foundations and the innovative therapies designed to target specific biological pathways. Emphasizing major breakthroughs, the book examines how unraveling molecular mechanisms and developing targeted treatments are reshaping cancer care. Furthermore, it discusses the growing influence of personalized medicine, offering insights into how genetic profiles and tumor characteristics guide individualized therapies. Users will find this to be an indispensable reference for professionals in cancer research, pharmacology, oncology, and personalized medicine.The book also addresses the challenges of drug resistance, recent advances in immunotherapy, and emerging strategies for improving patient quality of life. By presenting case studies, clinical trial outcomes, and future perspectives, the book equips readers with a thorough understanding of the complexities and opportunities present in modern cancer pharmacology.
    • Capsaicin, the Pungent Principle in Hot Pepper

      • 1st Edition
      • March 1, 2026
      • Arpad Szallasi
      • English
      • Hardback
        9 7 8 0 4 4 3 3 0 2 0 2 2
      • eBook
        9 7 8 0 4 4 3 3 0 2 0 3 9
      Capsaicin, the Pungent Principle in Hot Pepper: From Basic Pharmacology to Therapeutic Applications explores capsaicin's biological and pharmacological characteristics, from its discovery and isolation to its receptor identification and antagonists. The book's structure is divided into three sections, starting with the historical development of research on capsaicin. This foundational section provides a thorough understanding of the compound's journey from a simple pungent ingredient to a significant element in pharmacological studies. The second part of the book delves into capsaicin’s biological effects and pharmacology, covering areas such as nociception, pain, salivary secretion, body temperature regulation, and blood pressure regulation.Finally, the book examines the clinical applications of capsaicin, discussing potential future developments in desensitization, pain relief, injections, effects on the tumor microenvironment, appetite control, and longevity. This book is invaluable for pharmacology researchers and clinicians in pain management and cancer, offering insights into the unique characteristics and therapeutic potential of capsaicin.
    • Medicinal Plants

      • 2nd Edition
      • February 1, 2026
      • Da-Cheng Hao + 1 more
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 7 8 3 2
      • eBook
        9 7 8 0 4 4 3 4 1 7 8 4 9
      Medicinal Plants: Chemistry, Biology, and Omics, Second Edition is a reference to help researchers identify and master the patterns in the distribution of medicinal compounds on the phylogenetic tree to explore new drug resources and develop novel therapies against different diseases. The book provides a deeper understanding of how the interrelationship between phytometabolites, bioactivities and omics techniques facilitates sustainable conservation and application of phytomedicine resources. Now in 2nd edition, the contents have been updated to include topics as machine learning applications, geographic distribution of phytometabolites, comparative analysis of alkaloids, expanded coverage of selected taxa, and conditions like cardiovascular disease and cancer. The book is structured around chemotaxonomy. After an introduction and review of taxonomy, chemistry, biology and omics, the authors dive into a taxon-guided exploration of medicinal resources for Fritillaria, Chelidoniae, Dichocarpum, Aconitum, Cimicifugeae, Clematis, Potentilla, Rubus, Cannabis, and other taxa. All chapters follow a similar and consistent structure, offering detailed information on each of them. Researchers in phytopharmacology can acquire in-depth understanding of the interrelationships between chemistry, biology and omics, as well as the implications of the link between phylogeny, phytometabolites and bioactivities in medical biotechnology and sustainability. Clinicians can better understand the principles of mutual interactions between phytometabolites and drug efficacy.
    • Brain Peptide Shuttles

      • 1st Edition
      • Volume 105
      • February 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 5 4 7 0
      • eBook
        9 7 8 0 4 4 3 4 1 5 4 8 7
      Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
    • Drug Metabolism in Diseases

      • 2nd Edition
      • December 1, 2025
      • Wen Xie
      • English
      • Hardback
        9 7 8 0 4 4 3 2 9 2 8 9 7
      • eBook
        9 7 8 0 4 4 3 2 9 2 9 0 3
      Drug Metabolism in Diseases: Leveraging Drug Metabolism and Disposition in Precision Medicine and Therapeutic Development, Second Edition provides essential knowledge for pharmaceutical scientists and biologists to understand the interplay between diseases and physiological conditions, impacting drug metabolism and its implications in personalized treatment. Expanded with six new chapters since the first edition, this updated book covers the latest scientific findings. Other important points include the book’s comprehensive reference on mutual effects between drug metabolism and diseases, implications in precision medicine, and therapeutic development. Pharmaceutical scientists, drug metabolism researchers, and research physicians will benefit from the expert insights provided.
    • Fundamentals of Biologicals Regulation

      • 2nd Edition
      • November 1, 2025
      • Rebecca Sheets + 6 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 9 8 8 7
      • eBook
        9 7 8 0 4 4 3 2 1 9 8 9 4
      Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines, Second Edition serves as an introduction to the international regulatory arena in which biologicals are developed, offering an overview of processes and insights into the scientific concepts underpinning global regulations. The book provides in-depth coverage of Quality by Design, Combination Products, Quality Target Product Profiles, Risk Management Plans, REMS, and switching from reliance on in vivo to in vitro analytical methods. It reflects new developments and processes accelerated by the COVID-19 vaccine experience, including emergency use authorizations and conditional marking authorizations. New pedagogic elements and case studies have been added to improve learning outcomes.This book provides multiple levels of readership, with guidance on basic concepts, a detailed look at regulatory challenges, and practical insights into how regulators consider regulatory science and regulatory process issues across various regions, with an emphasis on the European Medicines Agency and the U.S. Food and Drug Administration.
    • Machine Learning in Drug Development: Part 2

      • 1st Edition
      • Volume 65
      • November 1, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 7 6 3 4
      • eBook
        9 7 8 0 4 4 3 4 1 7 6 4 1
      Machine Learning in Drug Development: Part Two, Volume 65 in the Annual Reports on Medicinal Chemistry series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this volume explore Transforming Modern Drug Discovery with Machine Learning – Applications in Ligand-based Drug Design, Optimizing Multi-Modal Drug Design Through Computational Pocket Mapping and Data Integration, Harnessing AI for Nucleic Acid Drug Discovery: Small Molecule Targeting DNA and RNA, AI-aided Drug Development for Protein Degraders: Design, Lead Identification, and Optimization, and more.Additional section delve into Artificial Intelligence in the Development of Antiviral Drugs – Progress and Applications, Artificial Intelligence for Drug Target Identification, and Machine Learning in Proteomic Biomarker Discovery
    • Progress in Medicinal Chemistry

      • 1st Edition
      • Volume 64
      • October 31, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 3 0 3 9 8
      • eBook
        9 7 8 0 4 4 3 4 3 0 4 0 4
      Progress in Medicinal Chemistry, Volume 64 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors.
    • Machine Learning in Drug Development: Part 1

      • 1st Edition
      • Volume 64
      • October 24, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 3 6 5 0
      • eBook
        9 7 8 0 4 4 3 4 1 3 6 6 7
      Machine Learning in Drug Development: Part One, Volume 64 in the Annual Reports on Medicinal Chemistry series, highlights new advances in the field. Chapters in this release include Artificial Intelligence in Small Molecule and Nucleic Acid Research: A Review, AI-aided Drug Development for Protein Degraders: Design, Lead Identification, and Optimization, AI-aided Drug Development for Protein Degraders: Biology Validation, Disease-association, Drug Repurposing, Transforming Modern Drug Discovery with Machine Learning, Artificial Intelligence in the Development of Antiviral Drugs: Progress and Applications, Artificial Intelligence for Drug Target Identification, and Machine Learning in Proteomic Biomarker Discovery.